Katarina Vidojević
Research Subjects
Katarina Vidojević has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jelena Ivetić
Faculty of Technical Sciences, University of Novi Sad, 21102 Novi Sad, Serbia
1 shared publication - Jovana Dedeić
Faculty of Technical Sciences, University of Novi Sad, Novi Sad, Serbia
1 shared publication - Marija Delić
Faculty of Technical Sciences, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication - Srđan Milićević
Department for Fundamental Sciences, Faculty of Technical Sciences, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication
Latest Publications
- 1 December 2025
- Published by Faculty of Technical Sciences
- Vol. 10, 114-119
META-ANALYSIS OF IMMUNOTHERAPY OUTCOMES IN METASTATIC MELANOMA
Meta-analytic methods are essential for quantitative evidence synthesis, offering a statistical framework for model comparison and heterogeneity assessment. This paper revisits our previous work through a concise methodological review and model-comparison metaanalysis, illustrating adaptive model selection for binary outcomes. Thirteen studies (>6,000 patients) comparing monotherapy and combination regimens in metastatic melanoma immunotherapy were analyzed. Binary outcomes (benefit and risk rates) were pooled using fixed-effects (FEM), random-effects (REM), and generalized linear mixed models (GLMM), depending on heterogeneity. The results highlight how model choice influences pooled estimates and inference reliability, underscoring the importance of flexible statistical modeling in complex datasets.
- 1 December 2025
- Published by Faculty of Technical Sciences
- Vol. 10, 114-119
META-ANALYSIS OF IMMUNOTHERAPY OUTCOMES IN METASTATIC MELANOMA
Meta-analytic methods are essential for quantitative evidence synthesis, offering a statistical framework for model comparison and heterogeneity assessment. This paper revisits our previous work through a concise methodological review and model-comparison metaanalysis, illustrating adaptive model selection for binary outcomes. Thirteen studies (>6,000 patients) comparing monotherapy and combination regimens in metastatic melanoma immunotherapy were analyzed. Binary outcomes (benefit and risk rates) were pooled using fixed-effects (FEM), random-effects (REM), and generalized linear mixed models (GLMM), depending on heterogeneity. The results highlight how model choice influences pooled estimates and inference reliability, underscoring the importance of flexible statistical modeling in complex datasets.